Detalhe da pesquisa
1.
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.
Mol Ther
; 31(3): 616-630, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635967
2.
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019.
J Infect Dis
; 228(5): 542-554, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166076
3.
Higher Levels of Cerebrospinal Fluid and Plasma Neurofilament Light in Human Immunodeficiency Virus-Associated Distal Sensory Polyneuropathy.
Clin Infect Dis
; 76(6): 1103-1109, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310512
4.
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
J Med Virol
; 95(11): e29216, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988251
5.
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
Clin Infect Dis
; 74(11): 2010-2019, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453519
6.
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment.
J Neurovirol
; 28(3): 438-445, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674935
7.
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 224(11): 1839-1848, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677601
8.
Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates.
Antimicrob Agents Chemother
; 65(12): e0121621, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570651
9.
Epistasis and Pleiotropy Affect the Modularity of the Genotype-Phenotype Map of Cross-Resistance in HIV-1.
Mol Biol Evol
; 33(12): 3213-3225, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27678053
10.
Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
J Virol
; 90(2): 768-79, 2016 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512081
11.
Recombination accelerates adaptation on a large-scale empirical fitness landscape in HIV-1.
PLoS Genet
; 10(6): e1004439, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24967626
12.
Exploring the complexity of the HIV-1 fitness landscape.
PLoS Genet
; 8(3): e1002551, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22412384
13.
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.
BMC Bioinformatics
; 15: 77, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646213
14.
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
PLoS Pathog
; 8(7): e1002832, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910833
15.
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk.
J Perinatol
; 44(1): 28-34, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092879
16.
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure.
Retrovirology
; 10: 22, 2013 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432922
17.
Multiple genetic pathways involving amino acid position 143 of HIV-1 integrase are preferentially associated with specific secondary amino acid substitutions and confer resistance to raltegravir and cross-resistance to elvitegravir.
Antimicrob Agents Chemother
; 57(9): 4105-13, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733474
18.
Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors.
Antimicrob Agents Chemother
; 57(11): 5649-57, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24002090
19.
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 141(1): 43-53, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959396
20.
Substitutions at amino acid positions 143, 148, and 155 of HIV-1 integrase define distinct genetic barriers to raltegravir resistance in vivo.
J Virol
; 86(13): 7249-55, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22553340